Subgroup analysis in therapeutic trials;Análise de subgrupos em ensaios clínicos terapêuticos

Revista Portuguesa de Cardiologia

Volumn 21, Issue 3, 2002, Pages 339-346

  Vaz Carneiro, António ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Bias; Evidence based cardiology; Randomized controlled trials; Sub group analysis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

CARDIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG CHOICE; DRUG INDICATION; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTHESIS; MEDICAL DECISION MAKING; MEDICAL RESEARCH; METHODOLOGY; OUTCOMES RESEARCH; PATIENT SELECTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; REVIEW; RHEUMATIC DISEASE; STROKE; TREATMENT OUTCOME; TREATMENT PLANNING; COMPARATIVE STUDY; HEART DISEASE; STANDARD;

HEART DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036511260     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. User's guide to the medical literature. XIV. How to decide on the applicability of clinical trial results to your patients
2. Applying the findings of clinical trials to individual patients
3. Subgroup analysis: Primary and secondary
4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation
5. Users' guides to the medical literature. XX. Integrating research evidence with the care of the individual patient
6. Effect of carvedilol on survival in severe chronic heart failure
7. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
8. Secondary prevention of vascular disease by prolonged antiplatelet treatment
9. A randomized trial of aspirin and sulfinpyrazone in threatened stroke
10. Subgroup analysis and other (mis)uses of baseline data in clinical trials
11. Heart failure in outpatients: A randomized trial of digoxin versus placebo
12. What do subgroup analyses reveal about differential response to beta-blocker therapy? The beta-blocker heart attack trial experience
13. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
14. Lessons from overviews of cardiovascular trials
15. A consumer's guide to subgroup analysis
16. A controlled trial of digoxin in congestive heart failure
17. Subgroup analysis